Efficacy of rapid antigen self-testing for SARS-CoV-2 screening:Real-world evidence from a prospective cohort study  

作　　者：Yaoyue Hu Bin Peng Jie Fan Zhu Yang Jianjiang Xue Quanxin Long Jie Xia Yuan Hu Xuefei Cai Li Zhou Ailong Huang 

机构地区：[1]School of Public Health,Chongqing Medical University,Chongqing 400016,China [2]The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China [3]Clinical Laboratory,University-Town Hospital of Chongqing Medical University,Chongqing 401331,China [4]Key Laboratory of Molecular Biology on Infectious Diseases Designated by the Chinese Ministry of Education,Chongqing Medical University,Chongqing 400016,China

出　　处：《Genes & Diseases》2024年第5期88-90,共3页基因与疾病（英文）

基　　金：the State Laboratory of Respiratory Diseases,Guangzhou,China(No.TL22-15);the Municipal Natural Science Foundation of Chongqing,China(No.stc2020jscx-fyzxX0003);Chongqing Biomedical R&D Major Special Project(China)(No.CSTB2022TIAD-STX0013)。

摘　　要：Antigen rapid diagnostic tests(Ag-RDTs)have been considered and implemented as an important diagnostic and screening tool to identify SARS-CoV-2 infections in community settings.1 Ag-RDTs are less sensitive,particularly in asymptomatic populations,compared with laboratorybased viral nucleic acid amplification tests(NAATs)such as reverse transcription polymerase chain reaction(RT-PCR).2 However,taking into account the facts that Ag-RDTs are effective for identifying most contagious individuals,they are faster and less expensive than RT-PCR,as well as that RT-PCR could produce positive results for weeks to months after the infection,2 WHO recommends Ag-RDTs be offered as COVID-19 self-testing for screening purposes in addition to professionally administered testing services regardless of the community transmission level.

关 键 词：testing FASTER rapid 

分 类 号：R373[医药卫生—病原生物学]